scholarly journals Extensively drug-resistant tuberculosis treatment outcome in Iran: a case series of seven patients

2010 ◽  
Vol 14 (5) ◽  
pp. e399-e402 ◽  
Author(s):  
Mohammad R. Masjedi ◽  
Payam Tabarsi ◽  
Parvaneh Baghaei ◽  
Sara Jalali ◽  
Parisa Farnia ◽  
...  
Keyword(s):  
Treatment Outcome ◽  
Case Series ◽  
Tuberculosis Treatment ◽  
Drug Resistant ◽  
Drug Resistant Tuberculosis ◽  
Resistant Tuberculosis ◽  
Extensively Drug Resistant ◽  
Tuberculosis Treatment Outcome

scholarly journals Emergence of Low-level Delamanid and Bedaquiline Resistance During Extremely Drug-resistant Tuberculosis Treatment

2019 ◽  
Vol 69 (7) ◽  
pp. 1229-1231 ◽  
Author(s):  
Silke Polsfuss ◽  
Sabine Hofmann-Thiel ◽  
Matthias Merker ◽  
David Krieger ◽  
Stefan Niemann ◽  
...  
Keyword(s):  
Multidrug Resistant ◽  
New Drugs ◽  
Tuberculosis Treatment ◽  
Drug Resistant ◽  
Drug Resistant Tuberculosis ◽  
Low Level ◽  
Resistant Tuberculosis ◽  
Extensively Drug Resistant

Abstract Two new drugs, delamanid and bedaquiline, have recently been approved for treatment of multidrug-resistant and extensively drug-resistant (XDR) tuberculosis. Here, we report a case of clofazimine, bedaquiline, and low-level delamanid resistances acquired during treatment of a patient with XDR tuberculosis.

scholarly journals First Use of Bedaquiline in Democratic Republic of Congo: Two Case Series of Pre Extensively Drug Resistant Tuberculosis

2018 ◽  
Vol 06 (02) ◽  
pp. 125-134 ◽  
Author(s):  
Murhula Innocent Kashongwe ◽  
Leopoldine Mbulula ◽  
Brian Bakoko ◽  
Pamphile Lubamba ◽  
Murielle Aloni ◽  
...  
Keyword(s):  
Democratic Republic ◽  
Democratic Republic Of Congo ◽  
Case Series ◽  
Drug Resistant ◽  
Drug Resistant Tuberculosis ◽  
Republic Of Congo ◽  
Resistant Tuberculosis ◽  
Extensively Drug Resistant
Sign in / Sign up

Export Citation Format

Share Document